Fig. 4From: Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomasThe patient classification of the RISK score signature in cohorts stratified by conventional risk factors. a Cohorts stratified by MGMT promoter methylation status. b Cohorts stratified by patient age (≥ 60 vs. < 60 yrs). MGMT O-6-methylguanine-DNA methyltransferase, RT radiotherapy, TMZ temozolomideBack to article page